For Media

Argos Therapeutics, Inc. is developing fully personalized immunotherapies that target unique features of a patient’s disease. This new generation of personalized therapeutics trains the immune system to recognize and attack diseases. Argos’ scientific leadership in RNA-loaded dendritic cells and advanced manufacturing processes provide a platform that we believe can tackle a wide range of cancers and infectious diseases.

804758804480804027802241801686801567796672796351794572794431fd539e46-a93e-4135-8451-389b13848f49579711c5-13b8-4c50-9b2d-2f2a67330e1e86d42f2b-1bdf-4002-8db3-ef006efa0da64f5413fd-18e2-4f43-bb73-16fb90627c36e897ade1-a3bf-4883-83e9-0f89737c6f92833159d4-c1c6-47f9-9965-1b527cdfaf3a5adaf646-c8e9-4688-8400-324bb93b1c5058393312-8ab6-4db5-8faa-d7886a5da19f4b3cce63-1ec7-46eb-9496-a1a94a8ec60b90024061-2609-4dc4-ac8f-91090f02dd0fARGS_News_2015_1_23_General_Releases.pdfARGS_News_2015_1_22_General_Releases.pdfARGS_News_2015_1_20_General_Releases.pdfARGS_News_2015_1_9_General_Releases.pdfARGS_News_2015_1_6_General_Releases.pdfARGS_News_2015_1_6_General_Releases.pdfARGS_News_2014_11_25_General_Releases.pdfARGS_News_2014_11_24_General_Releases.pdfARGS_News_2014_11_13_General_Releases.pdfARGS_News_2014_11_13_General_Releases.pdf17524191861773420325153202178318077246153345419466123456789102015-1-23T11:0:0-5:02015-1-22T8:30:0-5:02015-1-20T8:30:0-5:02015-1-9T7:0:0-5:02015-1-6T16:30:0-5:02015-1-6T8:30:0-5:02014-11-25T9:35:0-5:02014-11-24T8:30:0-5:02014-11-13T16:5:0-5:02014-11-13T8:30:0-5:0892671892460892000890486889939889780884863884537882950882799General ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesDr. Fred Miesowicz Will Present a Case Study Review of Logistics of Cell Therapy Manufacturing on January 26th and Will Participate in a Breakfast Briefing on January 27thDr. Mark DeBenedette Will Discuss the Use of Multi-Color Flow Cytometry to Monitor T-Cell Responses During the 7th Immunotherapeutics and Immunomonitoring Conference on January 29th in San DiegoDr. Charles Nicolette Will Discuss Immunotherapy for Cancer Treatment on January 27thCollaboration Will Support Commercial Production of Argos Immunotherapies Based on the Arcelis(R) Technology PlatformRed Herring Editorial Team Highlights the Argos Arcelis(R) Technology Platform for Developing Fully Personalized Immunotherapies as Important Advance in the Life Science Market.Conference Call and Webcast Today, November 13th, at 4:30 p.m. ETArgos Therapeutics Chief Operating Officer to Speak at Phacilitate Cell & Gene Therapy Forum 2015Argos Therapeutics Director of Immunology to Speak at the GTCbio Novel Immunotherapeutics Summit 2015Argos Therapeutics Chief Scientific Officer to Speak at the Personalized Medicine World Conference 2015Argos Therapeutics Provides Update on Clinical Research for Investigational Fully Personalized Immunotherapy for the Treatment of HIVArgos Therapeutics to Present at Biotech Showcase 2015Argos Therapeutics and Saint-Gobain Announce Agreement for Production of Disposables Used in Automated Manufacturing of Fully Personalized ImmunotherapiesArgos Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare ConferenceArgos Therapeutics Receives 2014 Red Herring North America Top 100 AwardArgos Therapeutics Reports Third Quarter 2014 Financial Results and Operational HighlightsPhilippe Van Holle Joins Argos Therapeutics Board of Directors818181818181818181812015201520152015201520152014201420142014No Error0

Argos Therapeutics Chief Operating Officer to Speak at Phacilitate Cell & Gene Therapy Forum 2015
Read more

Argos Therapeutics Director of Immunology to Speak at the GTCbio Novel Immunotherapeutics Summit 2015
Read more

Argos Therapeutics Chief Scientific Officer to Speak at the Personalized Medicine World Conference 2015
Read more

Argos Therapeutics Provides Update on Clinical Research for Investigational Fully Personalized Immunotherapy for the Treatment of HIV
Read more

Argos Therapeutics to Present at Biotech Showcase 2015
Read more

Argos Therapeutics and Saint-Gobain Announce Agreement for Production of Disposables Used in Automated Manufacturing of Fully Personalized Immunotherapies
Read more

Argos Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference
Read more

Argos Therapeutics Receives 2014 Red Herring North America Top 100 Award
Read more

Argos Therapeutics Reports Third Quarter 2014 Financial Results and Operational Highlights
Read more

Philippe Van Holle Joins Argos Therapeutics Board of Directors
Read more